Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pharmacogenomics J. 2016 Mar 15;17(4):351–359. doi: 10.1038/tpj.2016.18

Fig. 4. Correlation of TSA with drug IC50 and mRNA expression across 102 blood-derived GDSC cell lines.

Fig. 4

(A) Correlation of TSA DRS with IC50 of 125 drugs from the GDSC database (B) TSA DRS is anticorrelated with HDAC2 mRNA expression, (C) TSA DRS is correlated with ABT-263 (Bcl2 inhibitor) IC50 (D) TSA DRS is correlated with AZD6244 (MEK inhibitor) IC50 (E) TSA DRS is correlated with MEK mRNA expression.